NFKB1 and hyperuricemia: On the other hand, hyperuricemia induces insulin resistance through suppression of both basal and glucose-stimulated insulin secretion [56], induction of β-cell dysfunction through NF-κB signaling pathway [57], reduction of serum nitric oxide levels [58] and bioavailability [59].